SEC Filing Summary: TECHPRECISION CORP (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Techprecision Corporation on July 15, 2010. The filing primarily addresses Item 5.02, detailing the appointment of a new Chief Executive Officer (CEO) and director. The company is incorporated in Delaware and maintains its principal executive offices in Westminster, MA.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and employment terms.
Material Changes
The material change reported is the appointment of Mr. James Molinaro as Chief Executive Officer and a member of the Board of Directors, effective July 21, 2010. Mr. Molinaro previously served as a principal of Solvinti, LLC and as CEO of Akrion Systems.
Guidance, Outlook, and Management Commentary
The filing outlines the specific compensatory arrangements for the new CEO under an Offer Letter dated July 15, 2010:
- Base Salary: $300,000 annually, subject to Board adjustment.
- Performance Bonus: Eligible for up to 50% of the annual base salary.
- Equity Grant: An option to purchase 1,000,000 shares of common stock under the 2006 Long Term Incentive Plan. The exercise price will be the average closing price for the first five trading days following the grant date. Vesting terms are to be determined by the Board.
- Severance Provisions:
- Termination without "Cause" or resignation for "Good Reason" entitles Mr. Molinaro to 12 months of base salary and health benefits.
- Termination within a specific window surrounding a change of control increases severance to 18 months and triggers immediate vesting of all unvested options.
- Definitions: "Cause" includes insubordination, criminal conviction involving dishonesty, or neglect of duties. "Good Reason" includes material salary reduction, breach of contract, or material adverse change in duties.
The filing also notes the execution of a Confidentiality Agreement containing non-competition provisions effective for one year post-employment.
Investor Verification Checklist
- Verify the exact grant date and exercise price of the 1,000,000 share option grant once finalized by the Board.
- Review the specific vesting schedule for the option grant, which is not detailed in this summary.
- Confirm the company's current cash position to assess the ability to fund the $300,000 base salary and potential severance obligations.
- Examine the full text of the Offer Letter (Exhibit 10.1) and Confidentiality Agreement (Exhibit 10.2) for additional covenants.